Share

As our organization grows and we are doing more and more things, there is an ever greater need for specialist knowledge and guidance to help inform our decisions as a company. We rely on the advice and expertise of both our scientific and business advisors and we have added to them this week with two new experts joining us.

We are delighted to announce that Steven A. Garan has joined our scientific advisory board. Steven is the Director of Bioinformatics at the Center for Research & Education on Aging (CREA) and serves on its advisory board, and he is a researcher at the Lawrence Berkeley National Laboratory. While at the University of California, Berkeley, he played a major role in the invention and the development of the Automated Imaging Microscope System (AIMS), and he collaborated for many years with a group from Paola S. Timiras’ lab, researching the role that caloric restriction plays in maintaining estrogen receptor-alpha and IGH-1 receptor immunoreactivity in various nuclei of the mouse hypothalamus.

Steven was also the director of the Aging Research Center and is a leading scientist in the field of aging research. His numerous publications include articles on systems biology, the effects of caloric restriction on the mouse hypothalamus, and the AIMS. He is best known for coining the word “Phenomics”, which was defined in “Phenomics: a new direction for the study of neuroendocrine aging”, an abstract published in the journal Experimental Gerontology.

We are also pleased to announce that Michael Kope has joined our industry advisory board and will support us with business expertise and guidance. Mike is the CEO and co-founder of the SENS Research Foundation, and he received his J.D. from the University of Michigan in 1990. He has served as the University of Michigan’s Intellectual Property Counsel, as Director of Corporate Development for Aviron and for MedImmune, Inc., and as CEO and officer of a number of start-ups in the biotechnology space.

He specializes in business development and consulting and is widely experienced with biotechnology organizations. Mike has negotiated a broad range of business acquisition and partnership agreements, designed strategies for technology protection and promotion in many fields of research, and facilitated a number of successful startups.

About the author

Steve Hill

Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 500 articles on the topic as well as attending various medical industry conferences. In 2019 he was listed in the top 100 journalists covering biomedicine and longevity research in the industry report – Top-100 Journalists covering advanced biomedicine and longevity created by the Aging Analytics Agency. His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, and, Keep me Prime, and New Economy Magazine. Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project. In 2015 he led the Major Mouse Testing Program (MMTP) for the International Longevity Alliance and in 2016 helped the team of the SENS Research Foundation to reach their goal for the OncoSENS campaign for cancer research.
  1. August 12, 2018

    Hi,

    I think the anti aging world should have more investors. So here this news is wonderful. I hope you will become more robust overtime and become more efficient at fighting aging. Congrats !

Write a comment:

*

Your email address will not be published.

© 2018 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

       Powered by MMD